Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $10.1250 (1.81%) ($10.1250 - $10.1250) on Wed. May. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.73% (three month average) | RSI | 31 | Latest Price | $10.1250(1.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.1% a day on average for past five trading days. | Weekly Trend | EDIT declines -6.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(65%) IWC(60%) IWO(58%) IBUY(57%) IWM(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.865% in a week (0% probabilities). VIXM(-24%) UUP(-15%) TBT(-10%) VXX(-9%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.865% (StdDev 5.73%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-15.71(-255.16%) | Resistance Level | $11.94 | 5 Day Moving Average | $10.56(-4.12%) | 10 Day Moving Average | $10.86(-6.77%) | 20 Day Moving Average | $11.94(-15.2%) | To recent high | -52.5% | To recent low | 1.8% | Market Cap | $629m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |